A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

Clinical trial NCT00225589 · COMPLETED

Trial details

NCT number: NCT00225589
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesteremia

Start date: 2002-08-01
Primary completion: 2006-05-01
Enrollment: 840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.